BST2 and systemic sclerosis: EGFR+ SSc fibroblasts also expressed higher levels of interferon inducible genes (IFI27, BST2), which have been shown to correlate with SSc disease severity (34, 35), and IL6, a profibrotic cytokine whose inhibition slows SSc-associated lung fibrosis (3).